The course was recorded on May 9, 2026, at the ASLMS Annual Conference.

Course Description: This session will have brief presentations of practice management pearls by faculty that have very successful practices. They will share some of what made them successful, focusing on practical steps you can take directly to your own practice to build your success.

COURSE DIRECTORS: Anne M. Chapas, MD; Elizabeth L. Tanzi, MD, FAAD

FACULTY PANELISTS:  Jennifer L. MacGregor, MD; Terrence C. Keaney, MD – Founder, SkinDC; Nkemjika Ugonabo, MD, MPH – UnionDerm; Albert Einstein College of Medicine; Brenda LaTowsky, MD – Cosmetic Dermatologist, Clear Dermatology & Aesthetics Center; Jessica G. Labadie, MD – Dermatologist, SkinCare Physicians, Chestnut Hill, Massachusetts; Amy F. Taub, MD FAAD - Founder/Managing Physician/Assistant Professor Advanced Dermatology and Skinfo/Advanced Dermatology, A Forefront Dermatology Practice/Northwestern University Medical School; Jennifer M. Segal, MD

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Build a successful cosmetic energy-based practice.
2. Effectively incorporate social media into your practice.

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Building a Patient Centered Practice | Jennifer L. MacGregor, MD

Introducing New Technology | Terrence C. Keaney, MD – Founder, SkinDC

Social Media Strategies | Nkemjika Ugonabo, MD, MPH – UnionDerm; Albert Einstein College of Medicine

HR Strategies for Hiring, Retention and Firing | Brenda LaTowsky, MD – Cosmetic Dermatologist, Clear Dermatology & Aesthetics Center

How to Deal with the Unhappy Cosmetic Patient | Jessica G. Labadie, MD – Dermatologist, SkinCare Physicians, Chestnut Hill, Massachusetts

Malpractice Strategies and Dealing with a Lawsuit | Amy F. Taub, MD FAAD - Founder/Managing Physician/Assistant Professor Advanced Dermatology and Skinfo/Advanced Dermatology, A Forefront Dermatology Practice/Northwestern University Medical School

Preventing and Dealing with Cyber Attack | Jennifer M. Segal, MD

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Jennifer L. MacGregor, MD discloses the following financial relationships: UnionDerm: Employee
• Terrence C. Keaney, MD discloses the following financial relationships: AbbVie, Allergan: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria, Speakers' Bureau; Alastin Skincare, Inc./Galderma: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria; Merz Aesthetics: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria, Speakers' Bureau; Solta Medical: Consulting Fees (e.g., advisory boards), Honoraria; Sun Pharma: Consulting Fees (e.g., advisory boards), Honoraria
• Nkemjika Ugonabo, MD, MPH discloses the following financial relationships Lumenis Be Ltd.: Consulting Fees (e.g., advisory boards); Solta Medical: Consulting Fees (e.g., advisory boards)
• Brenda LaTowsky, MD discloses the following financial relationships Allergan Aesthetics, an AbbVie Company: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution); Croma: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution); Galderma: Contracted Research (Principal Investigators must provide information, even if received by the institution); Merz Aesthetics: Contracted Research (Principal Investigators must provide information, even if received by the institution); SINCLAIR: Contracted Research (Principal Investigators must provide information, even if received by the institution); Zeltiq Aesthetics, Inc., an AbbVie Company: Contracted Research (Principal Investigators must provide information, even if received by the institution)
• Jessica Labadie, MD discloses the following financial relationships: AbbVie: Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria; Cortex: Contracted Research (Principal Investigators must provide information, even if received by the institution); Galderma: Contracted Research (Principal Investigators must provide information, even if received by the institution); Nordberg Clinical: Contracted Research (Principal Investigators must provide information, even if received by the institution); Veradermics: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria
• Amy F. Taub, MD FAAD discloses the following financial relationships: AbbVie: Consulting Fees (e.g., advisory boards), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); Cynosure / Lutronic: Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria; OneSkin: Consulting Fees (e.g., advisory boards); Sofwave Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution), Speakers' Bureau

ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.8 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 9, 2026, at the ASLMS Annual Conference.

Course Description: Laser treatment of tattoos and pigmentary disorders in skin of color carries a higher risk of complications and requires specialized clinical expertise. This course provides an evidence-based, practical approach to device selection, and parameter optimization to minimize complications in darker skin types.

COURSE DIRECTORS: Girish S. Munavalli, MD, MHS, FACMS – Medical Director/Founder, Dermatology Laser and Vein Specialists of the Carolinas; Nazanin Saedi, MD

FACULTY PANELISTS: B. S. Chandrashekar, MD; William Kwan, MD, FAAD; Omar A. Ibrahimi, MD, PhD; Boncheol L. Goo, MD, MSc 

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Select appropriate laser devices for tattoo removal and pigmentary disorders in Fitzpatrick skin types IV–VI based on diagnosis and patient-specific risk factors.
2.  Implement evidence-based peri-procedural strategies to reduce pigmentary complications in skin of color.

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

The Science of Dyspigmentation | B. S. Chandrashekar, MD

Tattoo Removal 360 | William Kwan, MD, FAAD – Physician, Golden State Dermatology Beverly Hills

Minimizing Pigment in Skin of Color | Omar A. Ibrahimi, MD, PhD – Founding Medical Director, Connecticut Skin Institute

Best Practices for Treating Skin of Color | Boncheol L. Goo, MD, MSc – Chief Director, Naeum Dermatology and Aesthetics Clinic, Seoul, Korea

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Girish S. Munavalli, MD, MHS, FACMS discloses the following financial relationships: Allergan Abbvie: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Benev: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Candela: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau, Stock Options Holder; Evolus: Consulting Fees (e.g., advisory boards), Honoraria; Lumenis: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Lutronic: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Sofwave: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Sofwave Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution), Stock Options Holder
• Nazanin Saedi, MD discloses the following financial relationships: Aerolase: Consulting Fees (e.g., advisory boards); Alastin Skincare, Inc./Galderma: Consulting Fees (e.g., advisory boards); Cartessa Aesthetics: Consulting Fees (e.g., advisory boards); Epionce: Consulting Fees (e.g., advisory boards); Grande Cosmetics: Consulting Fees (e.g., advisory boards); Hydrafacial: Consulting Fees (e.g., advisory boards); Revision Skin Care: Contracted Research (Principal Investigators must provide information, even if received by the institution); Sciton Inc.: Consulting Fees (e.g., advisory boards)
• William Kwan, MD, FAAD discloses the following financial relationships: Candela: Speakers' Bureau; Removery LLC.: Consulting Fees (e.g., advisory boards), Employee
• Omar A. Ibrahimi, MD, PhD, discloses the following financial relationships: AbbVie: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Accure Acne: Consulting Fees (e.g., advisory boards); Cynosure-Lutronic: Consulting Fees (e.g., advisory boards); Cytrellis: Consulting Fees (e.g., advisory boards) (Ongoing); Pfizer: Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Quthero: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Regeneron Pharmaceutical: Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (); Unilever: Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing)
• Boncheol L. Goo, MD, MSc, discloses the following financial relationships: AGNES Medical: Stock Options Holder, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); Classys: Consulting Fees (e.g., advisory boards); Colgage-Palmolive: Consulting Fees (e.g., advisory boards); Joonghun Pharma: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria; SheNB: Consulting Fees (e.g., advisory boards)

ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.6 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 9, 2026, at the ASLMS Annual Conference.

Course Description:

Artificial intelligence is rapidly reshaping aesthetic medicine from imaging and diagnosis to treatment planning, workflow efficiency, and safety monitoring. This session demystifies practical AI for lasers, energy-based devices, injectables, and body contouring. Faculty will translate core concepts into everyday clinical use. We will review evidence, real-world cases, and regulatory considerations.

COURSE DIRECTORS: Lilit Garibyan, MD, PhD; Zakia Rahman, MD

FACULTY PANELISTS: Kerrie Jiang, MSN, NP; Arlene Ruiz de Luzuriaga, MPH, MBA, MD – Dermatologist, University of Chicago, Dept. of Medicine, Section of Dermatology; Diala Haykal, MD – Laser Aesthetic Medical Center; Shlomit Halachmi, MD, PhD – Founder and CEO, Building 66

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Evaluate an AI tool using clinically relevant performance metrics
2. Discuss AI uses with lasers/EBDs/injectables

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

How Industry R&D Can Leverage AI | Kerrie Jiang, MSN, NP

Ethical Consideration in the Use of AI | Arlene Ruiz de Luzuriaga, MPH, MBA, MD – Dermatologist, University of Chicago, Dept. of Medicine, Section of Dermatology

AI In Energy Based Devices | Diala Haykal, MD – Laser Aesthetic Medical Center

Behind the Paradigm for AI in Assessing Skin Lesions | Shlomit Halachmi, MD, PhD – Founder and CEO, Building 66

BACKGROUND REQUIREMENTS:

Participants with a basic understanding of skin biology and physics will derive maximal benefit from the presentations, however, all meeting attendees are welcome to attend and contribute.

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Lilit Garibyan, MD, PhD discloses the following financial relationships Annecy Bio: Biomedical Start-up Owner/Employee (that has begun the regulatory process), Owner/Co-Owner Founder/Co-Founder; Brixton Bio: Biomedical Start-up Owner/Employee (that has begun the regulatory process), Consulting Fees (e.g., advisory boards), Owner/Co-Owner Founder/Co-Founder; Clarity Cosmetics: Investor, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); EyeCool: Biomedical Start-up Owner/Employee (that has begun the regulatory process), Owner/Co-Owner Founder/Co-Founder; Face of Angel: Founder - non-profit, Owner/Co-Owner Founder/Co-Founder; Magic Wand Initiative: co-founder - educational program, Owner/Co-Owner Founder/Co-Founder; Mass General Hospital: Assigned to Mass General Hospital who receives royalties and IP right from my inventions, Employee, Royalty/Patent Beneficiary; Massachusetts General Hospital; Massachusetts Dermatology Associates: Employee (Ongoing); MVS: Owner/Co-Owner Founder/Co-Founder; NIH: Contracted Research (Principal Investigators must provide information, even if received by the institution); Sinclair Aesthetic: Honoraria
• Zakia Rahman, MD discloses the following financial relationships: AbbVie, Allergan: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Estée Lauder: Consulting
• Kerrie Jiang, MSN, NP discloses the following financial relationships: AGNES Medical: Consultant; Akeyna: Consultant; Cytrellis Biosystems, inc: Consulting Fees (e.g., advisory boards); Merz Aesthetics: Former Employee; SnigTag/BioDesign Stanford: Consultant

ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.6 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

 The course was recorded on May 9, 2026, at the ASLMS Annual Conference.

Course Description: Photobiomodulation (PBM) is rapidly becoming a game changer in procedural dermatology and laser medicine as wavelength specificity, devices, and dosing strategies mature. This session reviews mechanisms and practical protocols for red/NIR, blue, and green light therapies, with a focus on clinical integration: post-procedure recovery, wound healing, Mohs recovery, flaps/grafts, and high-yield medical/aesthetic indications including acne, AKs, photodamage/wrinkles, inflammation, hair growth, pigmentary disorders, oral ulcerations, and radiation dermatitis. We’ll cover device selection, dosing, timing, safety, and combination strategies with energy-based devices and topical agents. Expert panel discussion and case-based learning will provide a clear framework for incorporating PBM into multimodal plans to reduce downtime and improve outcomes.

COURSE DIRECTORS: Ellen S. Marmur, MD; David M. Ozog, MD

FACULTY PANELISTS: Rox Anderson, MD –Professor (dermatology) Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Robert A. Weiss, MD, FAAD – Assoc Prof of Dermatology, U of MD; Ellen S. Marmur, MD – Owner/Founder, Marmur Medical & MMSkincare; Jody Comstock, MD – Cosmetic and Procedural Dermatologist, Skin Spectrum; David M. Ozog, MD – Department Chair, Henry Ford Health, Department of Dermatology, Detroit, MI; Faculty:  Jared Jagdeo, MD, MS – Dermatologist, SUNY Downstate

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Describe the key biological mechanisms by which red, blue, and green light influence skin biology in photobiomodulation (PBM)—including wavelength-dependent targets, depth of penetration, and downstream effects on inflammation, oxidative signaling, neuromodulation/pain, microcirculation, and tissue remodeling—and explain why these mechanisms matter when translating PBM into real-world dermatologic and aesthetic outcomes.
2. Identify evidence-based clinical indications for PBM across dermatology and aesthetics, and match the right wavelength (and delivery approach) to common conditions by considering the primary therapeutic goal (anti-inflammatory vs antimicrobial vs pigment modulation vs pain/neuromodulation vs wound repair), tissue depth, skin type, and procedural context—while recognizing where the evidence is strong, emerging, or mixed.
3. Apply practical PBM treatment protocols in clinic, including how to choose and standardize parameters (irradiance, fluence, pulse structure when relevant, treatment duration, spot size/coverage, frequency, and course length), how to time PBM relative to procedures (pre-conditioning, immediate post-procedure, and recovery phase), and how to use combination strategies (e.g., PBM with lasers/energy devices, injectables, topicals, wound care, or systemic approaches) without compromising safety or efficacy.
4. Integrate PBM into multimodal treatment plans and post-procedure recovery pathways by building condition-specific and procedure-specific workflows (patient selection, contraindications/precautions, documentation, and outcome tracking), setting realistic expectations, and leveraging PBM as an adjunct to improve comfort, shorten downtime, support barrier repair, and enhance overall patient-reported and clinician-rated outcomes.

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Mechanisms of Action and Validation of Early Photobiomodulation Research | Rox Anderson, MD –Professor (dermatology) Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Clinical Use and Early Research: Darkness Before the Dawn | Robert A. Weiss, MD, FAAD – Assoc Prof of Dermatology, U of MD

Green Light Science: Biological Rationale, Dosing, and Emerging Evidence | Ellen S. Marmur, MD – Owner/Founder, Marmur Medical & MMSkincare

Laser for Tattoos and Pigmented Lesions | Jody Comstock, MD – Cosmetic and Procedural Dermatologist, Skin Spectrum

Clinical Applications of PBM: Acne, Pigment, Inflammation, Actinic Keratoses, and Recovery | David M. Ozog, MD – Department Chair, Henry Ford Health, Department of Dermatology, Detroit, MI

Pitfalls, Adverse Effects, and Common Clinical Mistakes in PBM | Faculty:  Jared Jagdeo, MD, MS – Dermatologist, SUNY Downstate

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• David M. Ozog, MD discloses the following financial relationships: Biofrontera: Contracted Research (Principal Investigators must provide information, even if received by the institution); Cutera: Contracted Research (Principal Investigators must provide information, even if received by the institution); Galderma: Contracted Research (Principal Investigators must provide information, even if received by the institution); Michelson Diagnostics: Contracted Research (Principal Investigators must provide information, even if received by the institution); Sciton: Contracted Research (Principal Investigators must provide information, even if received by the institution)
• Rox Anderson, MD discloses the following financial relationships: AVAVA: Stock Options Holder; Cytrellis Biosystems: Stock Options Holder; MassGeneralBrigham: Royalty/Patent Beneficiary; R2 Dermatology: Consulting Fees (e.g., advisory boards)
• Robert A. Weiss, MD, FAAD discloses the following financial relationships: Allergan/Abbvie: Contracted Research (Principal Investigators must provide information, even if received by the institution); Boston Aesthetics: Contracted Research (Principal Investigators must provide information, even if received by the institution); Cynosure Lutronic: Contracted Research (Principal Investigators must provide information, even if received by the institution); Fotona: Contracted Research (Principal Investigators must provide information, even if received by the institution); Galderma Laboratories: Contracted Research (Principal Investigators must provide information, even if received by the institution); Jetema: Contracted Research (Principal Investigators must provide information, even if received by the institution); Lutronic: Contracted Research (Principal Investigators must provide information, even if received by the institution); Medytox: Contracted Research (Principal Investigators must provide information, even if received by the institution); Novoxel: Contracted Research (Principal Investigators must provide information, even if received by the institution)
• Jody Comstock, MD – Cosmetic and Procedural Dermatologist, Skin Spectrum, discloses the following financial relationships: L'oreal: Honoraria; Revance Aesthetics: Consulting Fees (e.g., advisory boards), Honoraria; SkinBetter Science: Consulting Fees (e.g., advisory boards), Honoraria; SofWave: Honoraria; Solta Medical: Honoraria; ZO Skin Health, Inc: Consulting Fees (e.g., advisory boards)
•  Jared Jagdeo, MD, MS discloses the following financial relationships: Global MedTech: Consulting Fees (e.g., advisory boards)

ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 2.0 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 9, 2026, at the ASLMS Annual Conference.

Course Description: This session will feature expert presentations on the medical applications of laser and energy-based devices, delivered by experienced faculty. Attendees will gain insights into the optimal use of these technologies for a wide spectrum of cutaneous conditions. Topics will include strategies to avoid complications, maximizing patient outcomes, and make informed decisions regarding device selection to best fit your practice.

COURSE DIRECTORS: Ariel Eber, MD; Paul M. Friedman, MD

FACULTY PANELISTS: Kristen M. Kelly, MD; Arielle N.B Kauvar; Ariel Eber, MD; Jessica G. Labadie, MD; Mary Dick, MD; Emily L. Guo, MD; Taryn Murray, MD

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Varied approaches used with these devices
2. Safety techniques to maximize patient outcomes
3. How to select the appropriate laser or device in different clinical settings

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Laser Treatment of Vascular Lesions and Pediatric Lasers | Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine

Laser Treatment of Scars | Arielle N.B Kauvar, MD – Director, New York Laser & Skin Care

Pigmentary Disorders | Ariel Eber, MD – University of Miami

Rosacea | Jessica G. Labadie, MD – Dermatologist, SkinCare Physicians, Chestnut Hill, Massachusetts

Nasal Contouring | Mary Dick, MD – Assistant Professor of Dermatology, Rush University Medical Center

Laser Treatment in Skin of Color | Emily L. Guo, MD – Board-Certified Dermatologist, Dermatology and Laser Surgery Center, Houston, TX

Miscellaneous Cases | Taryn N. Murray, MD – Cleveland Clinic

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Kristen M. Kelly, MD discloses the following financial relationships: Bausch Health: Investigator; MundiPharma, Allergan, Syneron Candela, Light Sciences Oncology, Novartis, Sciton, and ThermiRF: Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing)
• Arielle N.B Kauvar, MD discloses the following financial relationships: Acclaro: Honoraria; Candela: Contracted Research (Principal Investigators must provide information, even if received by the institution); Sofwave: Consulting Fees (e.g., advisory boards)
• Jessica Labadie, MD discloses the following financial relationships: AbbVie: Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria; Cortex: Contracted Research (Principal Investigators must provide information, even if received by the institution); Galderma: Contracted Research (Principal Investigators must provide information, even if received by the institution); Nordberg Clinical: Contracted Research (Principal Investigators must provide information, even if received by the institution); Veradermics: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria
• Emily L. Guo, MD discloses the following financial relationships: Solta Medical: Speakers' Bureau
• Taryn N. Murray, MD discloses the following financial relationships: Acclaro: Consulting Fees (e.g., advisory boards), Speakers' Bureau; R2 Technologies: Consulting Fees (e.g., advisory boards)
• ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 2.0 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 8, 2026, at the ASLMS Annual Conference.

Course Description: Medical lasers and energy-based devices are relatively under-utilized on patients with skin of color due to concerns regarding risk of pigmentary and other complications in Fitzpatrick skin phototypes IV-VI. 

Medical lasers and energy-based devices can be used safely and effectively to treat a range of dermatologic concerns in patients with skin of color.  

Careful selection of device type, settings, pre-and post-procedure precautions are key to optimizing outcomes for energy-based treatments in skin of color.

COURSE DIRECTORS: Andrew Alexis, MD, MPH; Keyvan Nouri, MD, MBA

FACULTY PANELISTS: Eliot F. Battle, Jr., MD – CEO & Co-Founder, Cultura Dermatology & Plastic Surgery; Henry Hin Lee Chan, MD, PhD, FRCP – Hon Clinical Professor, University of Hong Kong; Andrew Alexis, MD, MPH – Vice Chair, Weill Cornell Medicine; Mukta B. Sachdev, MD(Derm) DD,DPD,DipDerm (UK) – Medical Director, MS Skin Centre; Hye Jin Chung, MD, MMSc – Associate Professor, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston MA

 LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Discuss optimal approaches to utilizing medical lasers and energy-based devices in patients with skin of color.
2. Identify safe and effective devices and treatment parameters for addressing dermatologic concerns in patients with skin of color.

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

The Art and Science of Treating Skin of Color with Lasers and Energy-based Devices | Eliot F. Battle, Jr., MD – CEO & Co-Founder, Cultura Dermatology & Plastic Surgery

Picosecond Laser and Nanosecond Laser Treatment of Pigmented Lesions in East Asian Populations | Henry Hin Lee Chan, MD, PhD, FRCP – Hon Clinical Professor, University of Hong Kong

Broad Applications of Lasers in the Management of Common Dermatologic Disorders in Skin of Color (Case Based) | Andrew Alexis, MD, MPH – Vice Chair, Weill Cornell Medicine

Treatment of Melasma and other Hyperpigmentation Disorders in South Asian Populations | Mukta B. Sachdev, MD(Derm) DD,DPD,DipDerm (UK) – Medical Director, MS Skin Centre

Laser/EBD Treatment Pearls for Acne Scarring and more! (Case Based) | Hye Jin Chung, MD, MMSc – Associate Professor, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston MA

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Keyvan Nouri, MD, MBA discloses the following financial relationships: iVeena Delivery Eye Drug Delivery systems: Bought with my own funds, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); Pfizer: Bought with my own funds, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed)
• Andrew Alexis, MD, MPH discloses the following financial relationships: AbbVie: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution); Aerolase: Equipment, Speakers' Bureau; Allergan: Consulting Fees (e.g., advisory boards); Almirall: Consulting Fees (e.g., advisory boards); Alphyn: Consulting Fees (e.g., advisory boards); Alumis: Consulting Fees (e.g., advisory boards); Amgen: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution); Apogee: Consulting Fees (e.g., advisory boards); Arcutis: Consulting Fees (e.g., advisory boards), Grants (funds to institution); Bausch Health: Consulting Fees (e.g., advisory boards); Beiersdorf: Consulting Fees (e.g., advisory boards); BMS: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Boehringer Ingelheim: Consulting Fees (e.g., advisory boards); Botanix: Consulting Fees (e.g., advisory boards); Canfield: Consulting Fees (e.g., advisory boards); Castle: Consulting Fees (e.g., advisory boards), Grants (funds to institution); Dermavant: Consulting Fees (e.g., advisory boards), Grants (funds to institution); Eli Lily: Consulting Fees (e.g., advisory boards); Elsevier: Royalty/Patent Beneficiary; Galderma: Consulting Fees (e.g., advisory boards), Grants (funds to institution); Genentech: Consulting Fees (e.g., advisory boards); HairDays: Consulting Fees (e.g., advisory boards); Incyte: Consulting Fees (e.g., advisory boards); Janssen: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Johnson & Johnson: Speakers' Bureau; Leo Pharma: Consulting Fees (e.g., advisory boards), Grants (funds to institution); L'Oreal: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Novartis: Consulting Fees (e.g., advisory boards); Ortho: Consulting Fees (e.g., advisory boards); Pfizer: Consulting Fees (e.g., advisory boards); Regeneron: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Sanofi-Genzyme: Speakers' Bureau; Sanofi-Regeneron: Consulting Fees (e.g., advisory boards); Springer: Royalty/Patent Beneficiary; Swiss American: Consulting Fees (e.g., advisory boards); Symrise: Consulting Fees (e.g., advisory boards); UCB: Consulting Fees (e.g., advisory boards); VisualDX: Consulting Fees (e.g., advisory boards); Wiley-Blackwell: Royalty/Patent Beneficiary; Wolters Kluwer Health: Royalty/Patent Beneficiary Kristen M. Kelly, MD discloses the following financial relationships: Bausch Health: Investigator; MundiPharma, Allergan, Syneron Candela, Light Sciences Oncology, Novartis, Sciton, and ThermiRF: Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing)
• Henry Hin Lee Chan, MD, PhD, FRCP discloses the following financial relationships: AbbVie Inc: Honoraria; AVAVA, LLC: Royalty/Patent Beneficiary, Stock Options Holder, Support Clinical Trial; Blossom Innovations, LLC: Royalty/Patent Beneficiary, Stock Options Holder; Boehringer Ingelheim (HK) Ltd: Honoraria; Clarity Cosmetics Inc: Stock Options Holder; Cutera, Inc: Support Clinical Trial; Cynosure, Inc.: Honoraria, Support Clinical Trial; Cytrellis Biosystems, Inc.: Stock Options Holder; Eli Lilly Asia Inc: Honoraria; Kyowa Kirin Asia Pacific Pte Ltd: Honoraria; Massachusetts General Hospital: Employee, Royalty/Patent Beneficiary; McGraw-Hill Companies: Royalty/Patent Beneficiary; R2 Dermatology, Inc  in San Ramon, CA, USA: Royalty/Patent Beneficiary, Stock Options Holder, Support Clinical Trial (consumable only); SofWave Medical Ltd.: Honoraria, Support Clinical Trial; Solta Medical HK Ltd: Honoraria; UCB Pharma (Hong Kong) Ltd: Honoraria
• Hye Jin Chung, MD, MMSc discloses the following financial relationships: Recens Medical: Research Funding; Sonoma pharmaceutical: Consulting Fees (e.g., advisory boards)
• ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.8 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 8, 2026, at the ASLMS Annual Conference.

Course Description: This session unites distinguished physicians from around the world to share regional perspectives on the practice of laser and aesthetic medicine. Faculty will explore how cultural values, patient expectations, regulatory environments, and regional trends influence aesthetic goals and treatment approaches across the globe. Attendees will gain a deeper understanding of global aesthetic philosophies, evolving cultural trends, and innovative techniques shaping international practice.

COURSE DIRECTORS: Lesley R. Clark-Loeser, MD FAAD; Mona Sadeghpour, MD

FACULTY PANELISTS: Mona Sadeghpour, MD; Shehnaz Z. Arsiwala, MD, DDV; Kentaro Oku, MD; David Kim, MD; Rafael M. Nunes, MD 

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

• Describe how cultural values, patient expectations, and regional norms influence aesthetic goals and treatment preferences across the world.
• Compare regional approaches to laser and aesthetic treatments, including technique selection, treatment intensity, and outcome prioritization.
• Identify emerging global trends and innovations shaping international aesthetic practice.

• Integrate global perspectives to inform more culturally sensitive and adaptable clinical decision-making in their own practices.

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Aesthetic Considerations in the Middle Eastern Patient | Mona Sadeghpour, MD

The New Indian Aesthetic: Balancing Tradition, Technology, and Regional Identity | Shehnaz Z. Arsiwala, MD, DDV - Director, Renewderm Skin, Hair, Lasers and Aesthetics Centre

What Comes After Efficacy and Safety? Re-evaluation of Aesthetic Medicine from Another Perspective | Kentaro Oku, MD – Director, Hills Grace Clinic

Kbeauty - Latest Innovations from Korea | David Kim, MD – Medical Director, Soho Dermatology

The Brazilian Edge: Redefining Energy-Based Aesthetics Through Integration | Rafael M. Nunes, MD

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Mona Sadeghpour, MD discloses the following financial relationships: Allergan Abbvie: Consulting Fees (e.g., advisory boards); Candela Corp: Honoraria; Galderma Laboratories: Speakers' Bureau; Solta Medical: Honoraria
• Kentaro Oku, MD discloses the following financial relationships: Cynosure Aesthetic and Medical APAC Pte Ltd: Honoraria; Jeisys: Honoraria; JMEC: Honoraria; Sofwave Medical: Honoraria
• Rafael M. Nunes, MD discloses the following financial relationships Biothera Medical: Consulting Fees (e.g., advisory boards); Mesoestetic: Consulting Fees (e.g., advisory boards); Pbserum: Consulting Fees (e.g., advisory boards)
• ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.5 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 8, 2026, at the ASLMS Annual Conference

Course Description: This session will cover the latest medical and surgical advances in maintaining and growing hair for our patients.  Laser hair stimulation, low level light, PRP, Hair transplantation, and oral medications are some of the topics that will be discussed.

COURSE DIRECTORS: Marc R. Avram, MD

FACULTY PANELISTS:  Marc R. Avram, MD – Clinical Professor of Dermatology, Weill Cornell Medical College/New York Presbyterian Hospital; Ronda S. Farah, MD - University of Minnesota, Department of Dermatology, Minneapolis, MN & Minneapolis Veterans Affairs Health Care System, Minneapolis, MN; Suleima Arruda, MD – Clinical Research Director, Sadick Dermatology, New York, NY; Douglas Wu, MD, PhD; Sungat K. Grewal, MD, FAAD; Jessica G. Labadie, MD; Merete Haedersdal, MD, PhD, DMSc

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Identify appropriate candidate selection for laser hair stimulation.
2. Identify appropriate candidate selection for hair transplant surgery

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Lasers, PRP, and Surgery for Restoring Hair Loss for Men and Women | Marc R. Avram, MD – Clinical Professor of Dermatology, Weill Cornell Medical College/New York Presbyterian Hospital

Exosomes - The Unbiased Truth | Ronda S. Farah, MD - University of Minnesota, Department of Dermatology, Minneapolis, MN & Minneapolis Veterans Affairs Health Care System, Minneapolis, MN

Lasers and Exosomes for Restoring Hair Loss | Suleima Arruda, MD – Clinical Research Director, Sadick Dermatology, New York, NY

Emerging Therapies for Androgenetic Alopecia | Marc R. Avram, MD – Clinical Professor of Dermatology, Weill Cornell Medical College/New York Presbyterian Hospital

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Marc R. Avram, MD discloses the following financial relationships: Lumenis Be Ltd.: Consulting Fees (e.g., advisory boards)
• Ronda S. Farah, MD discloses the following financial relationships: Lumenis: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution)

ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.8 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 8, 2026, at the ASLMS Annual Conference.

Course Description: Advances in laser surgery have expanded the range of light- and energy-based devices, yet many treatments remain siloed rather than strategically integrated. This session explores evidence-based protocols for combining modalities (e.g. lasers, light, ultrasound, radiofrequency, biostimulatory injectables, neuromodulators) to achieve synergistic improvement. Through case analysis and treatment sequencing strategies, attendees will learn how pairing technologies can enhance safety, efficacy, and patient satisfaction.

COURSE DIRECTORS: Sara Hogan, MD – Founder and Medical Director, Cosmedica Dermatology; Arisa E. Ortiz, MD – Professor of Dermatology; Director of Laser and Cosmetic Dermatology, University of California San Diego

FACULTY PANELISTS: Arisa E. Ortiz, MD – Professor of Dermatology; Director of Laser and Cosmetic Dermatology, University of California San Diego; Farah A. Moustafa, MD – Assistant Professor, Director Laser & Cosmetics Center, Tufts Medical Center; Sara Hogan, MD – Founder and Medical Director, Cosmedica Dermatology; Lisa Ishii, MD, FAAD – Board-Certified Dermatologist, Aesthetic Solutions; Chapel Hill, NC; Thomas M. Beachkofsky, MD - Director, Cutaneous Rehabilitation & Dermatology Laser Surgery Dermatology, James A Haley Veterans Hospital (Tampa, FL); Molly Wanner, MD, MBA – Massachusetts General Hospital

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Identify appropriate patient profiles for combination treatment strategies across different phototypes and indications.
2. Design evidence-based treatment plans that integrate multiple energy-based devices and injectables for synergistic outcomes.
3. Apply safe sequencing and parameter adjustment principles to minimize adverse events when stacking modalities.

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Combining Modalities for the Treatment of Melasma | Arisa E. Ortiz, MD – Professor of Dermatology; Director of Laser and Cosmetic Dermatology, University of California San Diego

Combining Modalities for Facial Rejuvenation | Farah A. Moustafa, MD – Assistant Professor, Director Laser & Cosmetics Center, Tufts Medical Center

Combining Modalities for the Treatment of Skin Laxity | Sara Hogan, MD – Founder and Medical Director, Cosmedica Dermatology

Combining Modalities for the Treatment of Textural Abnormalities | Lisa Ishii, MD, FAAD – Board-Certified Dermatologist, Aesthetic Solutions; Chapel Hill, NC

Combining Modalities for the Treatment of Scarring | Thomas M. Beachkofsky, MD - Director, Cutaneous Rehabilitation & Dermatology Laser Surgery Dermatology, James A Haley Veterans Hospital (Tampa, FL)

Combining Modalities - Devices, Injectables and More | Molly Wanner, MD, MBA – Massachusetts General Hospital

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Sara Hogan, MD discloses the following financial relationships: Allergan Aesthetics: Consulting Fees (e.g., advisory boards); Candela Medical: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Solta Medical: Speakers' Bureau; UpToDate: Royalty/Patent Beneficiary; Wontech USA: Speakers' Bureau
• Arisa E. Ortiz, MD discloses the following financial relationships: Aerolase: Consulting Fees (e.g., advisory boards); Alastin Skincare: Consulting Fees (e.g., advisory boards); Allergan: Consulting Fees (e.g., advisory boards), Speakers' Bureau (); Bausch Health: Consulting Fees (e.g., advisory boards); Cutera: Consulting Fees (e.g., advisory boards); Galderma: Consulting Fees (e.g., advisory boards); Procter and Gamble: Consulting Fees (e.g., advisory boards); Revance Therapeutics, Inc.: Contracted Research (Principal Investigators must provide information, even if received by the institution); Rodan + Fields: Consulting Fees (e.g., advisory boards); Sciton: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Smartgraft: Consulting Fees (e.g., advisory boards); Sofwave: Speakers' Bureau
• Farah A. Moustafa, MD discloses the following financial relationships: Candela: Speakers' Bureau
• Thomas M. Beachkofsky, MD discloses the following financial relationships: Acclaro: Honoraria; Lumenis Be: Consulting Fees (e.g., advisory boards); Lumenis Be: Clinical training
• Molly Wanner, MD, MBA discloses the following financial relationships: Akeyna: Owner/Co-Owner Founder/Co-Founder, Royalty/Patent Beneficiary, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); Bausch Health: Grant; Clarity Cosmetics: Stock Options Holder, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); EllaOla: Consulting Fees (e.g., advisory boards), Stock Options Holder; MGH: Royalty/Patent Beneficiary; MK2002 LLC: Owner/Co-Owner Founder/Co-Founder, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); Sorette: Consulting Fees (e.g., advisory boards), Stock Options Holder

ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 1.8 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The course was recorded on May 8, 2026, at the ASLMS Annual Conference.

Course Description: Vascular lasers can target red lesions, both vascular and non-vascular. This session will feature use of lasers for common vascular lesions as well as use of vascular lasers for other disorders.

COURSE DIRECTORS: Roy G. Geronemus, MD – Dermatologist, Director, Roy G. Geronemus MD; Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine

FACULTY PANELISTS:  Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine; Lisa M. Arkin, MD – Associate Professor, University of Wisconsin School of Medicine and Public Health, Madison, WI; Paul M. Friedman, MD;

Grewal, MD, FAAD; Jessica G. Labadie, MD; Merete Haedersdal, MD, PhD, DMSc

LEARNING OBJECTIVES:

At the end of the activity, learners should be able to:

1. Understand how devices work for treatment of vascular conditions.  
2. Apply the most current information and advanced techniques for treatment of vascular conditions

TARGET AUDIENCE:

This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.

PRESENTATIONS:

Intro to Vascular Lesion Treatment | Kristen M. Kelly, MD – Chair of Dermatology, University of California Irvine

Vascular Tumors and Malformations | Lisa M. Arkin, MD – Associate Professor, University of Wisconsin School of Medicine and Public Health, Madison, WI

Rosacea and Telangiectases | Paul M. Friedman, MD

Pediatric Vascular Laser Treatments | Roy G. Geronemus, MD – Dermatologist, Director, Roy G. Geronemus MD

DISCLOSURES:

The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.

All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

• Kristen M. Kelly, MD discloses the following financial relationships: Bausch Health: Investigator; MundiPharma, Allergan, Syneron Candela, Light Sciences Oncology, Novartis, Sciton, and ThermiRF: Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing)
• Lisa M. Arkin, MD discloses the following financial relationships: AMGEN: Contracted Research (Principal Investigators must provide information, even if received by the institution); Eli Lily: Consulting Fees (e.g., advisory boards); Eli Lily: Contracted Research (Principal Investigators must provide information, even if received by the institution); Merck: Consulting Fees (e.g., advisory boards)
• Paul M. Friedman, MD discloses the following financial relationships: Acclaro Corp: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Stock Options Holder; Allergan, Inc: Consulting Fees (e.g., advisory boards); Bausch Health: Contracted Research (Principal Investigators must provide information, even if received by the institution); Candela: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Speakers' Bureau; Solta Medical: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Veradermics, Inc.: Consulting Fees (e.g., advisory boards)
• Roy G. Geronemus, MD discloses the following financial relationships: Accure: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Allergan / Abbvie: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Avava: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Candela: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Cytrellis: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Lutronic/Cynosure: Consulting Fees (e.g., advisory boards) (), Contracted Research (Principal Investigators must provide information, even if received by the institution) (); New York Stem Cell Foundation: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Novoxel: Contracted Research (Principal Investigators must provide information, even if received by the institution) (); Sofwave: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Solta: Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
• ASLMS staff planners and reviewers have no relevant financial relationships to disclose.

ACCME Accreditation Statement:

The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:

The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits:

This enduring material is eligible for 2.0 credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.

Instructions for Learners to Receive Credit:

To receive a Certificate of Credit or a Certificate of Participation for this On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).

This course should take approximately 1.5 hours to complete. 

REFUND/CANCELLATION POLICY:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

• Refund requests will only be considered if made within 14 days of purchase.
• Refunds will only be considered if you have not yet started the course (no content viewed).
• Refunds are not available for missed live activities.
• Contact information@aslms.org to request a refund.

CONTACT INFORMATION:

For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283. 

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

DISCLOSURE OF OFF-LABEL USE:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.